Atlas Trials

BRAF V600 Mutation

21 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch BRAF V600 Mutation

RecordFirmDate
A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS) (NCT05546905)Pierre Fabre Medicament2022-06-23
Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg Formulations (NCT05103891)Pierre Fabre Medicament2021-09-03
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma (NCT04741997)H. Lee Moffitt Cancer Center and Research Institute2021-05-24
BRAF V600-mutated Lung Carcinoma Treated With the Combination of Dabrafenib-trametinib: a Retrospective Evaluation (NCT04775095)Intergroupe Francophone de Cancerologie Thoracique2021-03-08
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC) (NCT06749015)Fudan University2021-03-01
A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients (NCT04911998)Pierre Fabre Medicament2021-02-02
Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma (NCT04759846)Pierre Fabre Medicament2021-01-21
Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors (NCT04190628)ABM Therapeutics Corporation2020-06-16
Advanced Melanoma in Russian Experience (NCT03663647)MelanomaPRO, Russia2018-10-08
Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases (NCT03430947)Technische Universität Dresden2018-07-01
To Evaluate the Efficacy Beyond Progression of Vemurafenib+Cobimetinib Associated With Local Treatment Compared to Second-line Treatment in Patients With BRAFV600+ Metastatic Melanoma in Focal Progression With First-line+Vemurafenib+Cobimetinib. (NCT03514901)Intergruppo Melanoma Italiano2018-06-18

Track BRAF V600 Mutation automatically

Every clearance here is in the API, with alerts when new ones post.